Your browser doesn't support javascript.
loading
Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of ß-thalassemia intermedia and major.
Casu, Carla; Presti, Vania Lo; Oikonomidou, Paraskevi Rea; Melchiori, Luca; Abdulmalik, Osheiza; Ramos, Pedro; Rivella, Stefano.
Afiliação
  • Casu C; Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), PA, USA.
  • Presti VL; Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), PA, USA.
  • Oikonomidou PR; Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), PA, USA.
  • Melchiori L; Penteli's Children's Hospital, Pediatric Department, Athens, Greece.
  • Abdulmalik O; Adaptimmune Therapeutics Ltd., Abingdon, UK.
  • Ramos P; Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), PA, USA.
  • Rivella S; Novartis Pharma AG, Basel, Switzerland.
Haematologica ; 103(2): e46-e49, 2018 02.
Article em En | MEDLINE | ID: mdl-29097498
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esplenomegalia / Talassemia beta / Inibidores de Proteínas Quinases / Janus Quinase 2 Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esplenomegalia / Talassemia beta / Inibidores de Proteínas Quinases / Janus Quinase 2 Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article